You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 3, March 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Skin-Associated Lymphoid Tissue (SALT)-Related B-Cell Lymphoma (Primary Cutaneous B-Cell Lymphoma)

A Concept and a Clinicopathologic Entity

Benvenuto Giannotti, MD; Marco Santucci, MD

Arch Dermatol. 1993;129(3):353-355.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The existence of primary cutaneous B-cell lymphoma (pCBCL), ie, non-Hodgkin's B-cell lymphoma primarily presenting in the skin without any clinically and/or instrumentally detectable extracutaneous localization, has been only recently accepted. Indeed, B-cell lymphomas in the skin have long been considered as a sign of progression and dissemination of lymph node disease, and thus as associated with a poor prognosis, even in the absence of clinically detectable extracutaneous lesions. Conversely, B-cell lymphoproliferative disorders characterized by good response to local treatment, absence of extracutaneous localization, and favorable prognosis have been generally considered as reactive processes, thus being defined as pseudolymphomas.1-4 The increasing use of immunohistochemistry5,6 and, quite recently, of DNA analysis7 in clinicopathologic studies dealing with primary cutaneous B-cell lymphoproliferative disorders made clear that a monoclonal restriction of the surface immunoglobulins (sIg) is present in a consistent part of these cases.8-11 Therefore, as monoclonal proliferations of B-cells, they . . . [Full Text PDF of this Article]


Author Affiliations

II Department of Dermatology University of Florence Via della Pergola 58 1-50121 Firenze Italy; Institute of Morbid Anatomy and Histology University of Florence Viale G. B. Morgagni 85 50134 Firenze Italy



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.